Lorastad Sp.

OTC

Indications

• The symptomatic relief of allergic conditions including rhinitis and chronic urticaria.

Dosage

• Adults and children over 12 years of age: 2 spoons [10 mg], once daily.
• Children 2 – 12 years:
  + Weight > 30 kg: 10 ml [10 mg] (2 spoons), once daily.
  + Weight ≤ 30 kg: 5 ml [5 mg] (1 spoons), once daily.
• Patients with liver impairment:
  Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine. An initial dose of 10 ml (10 mg) every other day is recommended for adults and children weighing more than 30 kg, and for children weighing 30 kg or less, 5 ml (5 mg) every other day is recommended.
• Patients with renal impairment and Elderly:
  No dosage adjustments are required in patients with renal insufficiency.

Usage

• Lorastad Sp. is only administered orally.
• Use the 5 ml spoon inside the box to measure the volume.

• Patients who have shown hypersensitivity or idiosyncrasy to any of the ingredients.

Common:

• Headache,
• Nervousness,
• Fatigue.

• Loratadine should be administered with caution in patients with severe liver impairment.
• The administration of loratadine should be discontinued at least 48 hours before skin tests since antihistamines may prevent or reduce otherwise positive reactions to dermal reactivity index.
• Lorastad Sp. contains saccharose. Patients with rare hereditaryproblems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.
• It is preferable to avoid the use of loratadine during pregnancy. Loratadine is not recommended in breast-feeding women.
• Patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines.